Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Market Cap	1.87B -3.9%
Revenue (ttm)	183.57M -18.9%
Net Income	6.60M -33.6%
EPS	2.75 -33.6%
Shares Out	2.40M
PE Ratio	282.72
Forward PE	n/a
Dividend	1.00 (0.13%)
Ex-Dividend Date	n/a

Volume	498
Open	777.00
Previous Close	779.80
Day's Range	775.70 - 779.80
52-Week Range	681.00 - 929.00
Beta	-0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 29, 2026

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture, buy, sell, export, or deal in drugs, medicines, pharmaceuticals, chemicals, medical, and other preparations in Bangladesh. The company offers tablets, capsules, liquids, gel in tubes, and injectables for therapeutic areas, such as antiulcerant, antacid, antibacterial, antifungal, anti-protozoal, anti-helmintic, antituberculer, antispasmodic, antiasthmatic and antitussive, and analgesic and antipyretic. It also provides products for therapeutic areas in non-steroidal anti-inflammatory, steroi...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 474
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: AMBEEPHA

Financial Performance

In fiscal year 2025, Ambee Pharmaceuticals's revenue was 230.55 million, an increase of 5.13% compared to the previous year's 219.30 million. Earnings were 5.31 million, a decrease of -45.17%.